Course Outline
Click on the links below to preview selected pages from this course.
- Overview of Long COVID
- Background
- Background
- Complete this sentence. Routine assessment for long COVID conditions among persons who survived acute COVID-19 is critical to reducing the incidence a...
- Definitions of Long COVID
- Etiology of Long COVID
- Etiology of Long COVID
- When defining risk, an identifiable demographic group with the greatest frequency of development of long COVID is:
- Abnormal Immune Responses to SARS-CoV-2
- Abnormal Immune Responses to SARS-CoV-2 Infection
- Cells of the inborn immune system- neutrophils, monocytes, macrophages, and natural killer (NK) cells are associated with the immune response. The fun...
- An abnormal immunological response that can result in significant tissue damage in various body organ systems is:
- Patient Characteristics
- Patient Characteristics
- When comparing the level of risk for contracting long COVID between an unvaccinated white adult and a vaccinated white adult, what is the comparative ...
- Which of the following statements regarding a characteristic of a patient who develops long COVID is the least common characteristic?
- Long COVID Epidemiology
- Epidemiology
- A significant observation of persons who are more likely to develop long COVID is:
- Signs & Symtoms of Long COVID
- Current Clinical Laboratory Testing for Long COVID
- Current Clinical Laboratory Testing
- Clinical Laboratory Testing, continued
- Which laboratory assay would be of value in finding a serious identifiable disorder in a suspected long COVID patient?
- Serological Tests in Coronavirus Testing
- Serological Testing
- Serological Testing, continued
- SARS-CoV-2 Immunity
- Serological tests that can be used for indirect diagnosis of past exposure to SARS-CoV-2 (COVID-19) include which of the following assays?
- A positive laboratory test result for Anti-N IgM/IgG can specifically indicate which of the following?
- Future Direction: Emerging Clinical Laboratory Assays
- Future Directions: Research
- Centers for Disease Control and Prevention (CDC)
- CDC
- A future direction for the CDC is to:
- National Institute of Health
- References
Additional Information
Level of Instruction: Intermediate
Intended Audience: Medical laboratory scientists, medical laboratory technicians, laboratory supervisors, and laboratory managers. This course is also appropriate for MLS and MLT students and pathology residents.
Author Information: Dr. Turgeon is an author, professor, and consultant in medical laboratory science. Her books are Basic & Applied Clinical Laboratory Science, ed 8(2020); Immunology and Serology in Laboratory Medicine, ed 7 (2022); Clinical Hematology, ed 6 (2018); and Fundamentals of Immunohematology, ed 2. Foreign language editions have been published in Chinese, Spanish, and Italian. Dr. Turgeon has 18 years of university and 15 years of community college teaching and program administration experience. Guest speaking, scientific presentations, and technical and educational workshops complement her teaching and writing activities.
Reviewer Information: Andrew White, PA, did most of his undergraduate training at Ohio State University. He and his wife moved to Portland, where he ultimately earned his bachelor’s from the University of Western States. He then completed his formal education at Pacific University, where he earned his master’s degree in Physician Assistant Studies. Since graduating, he has practiced in Family Medicine, the last 5 of which have been in rural medicine. Andrew lives with his wife and three children in the beautiful Pacific Northwest.
Reviewer Information: Rory Huschka, M.Ed., MLS(ASCP), works on the content development team at MediaLab. He earned his BS degree in Medical Technology from North Dakota State University and later completed his Master's degree in Educational Leadership. Rory continues to teach as an adjunct for various MLS and MLT programs.
Course Description: This course evaluates the hypotheses associated with long COVID's basic disease pathogenesis, epidemiology, and related symptoms. It also identifies existing laboratory tests that aid long COVID patients, analyzes emerging clinical laboratory assays for immunological diagnosis, and compares the CDC and the NIH's future goals in treating long COVID patients.
